Login / Signup

Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors.

Takashi MatsumotoHirohisa OkabeYo-Ichi YamashitaToshihiko YusaRumi ItoyamaYosuke NakaoTakanobu YamaoNaoki UmzakiMasayo TsukamotoYuki KitanoTatsunori MiyataKota ArimaHidetoshi NittaHiromitsu HayashiKatsunori ImaiAkira ChikamotoHideo Baba
Published in: Surgery today (2018)
An SUVmax ≥ 2.0 on 18F-FDG PET/CT might be associated with higher malignant potential of PNETs.
Keyphrases
  • positron emission tomography
  • computed tomography
  • neuroendocrine tumors
  • pet ct
  • pet imaging
  • magnetic resonance imaging
  • dual energy
  • contrast enhanced
  • magnetic resonance
  • human health
  • climate change